PPCBPropanc Biopharma, Inc. · Nasdaq Capital Market · $28.93M mkt cap
Assessed Oct 8, 2026 · Float drift
Is the float you're seeing correct?
4.66M
Estimated float

Started from the 2026-10-01 outstanding count in the S-1.

Understated 57%
2.96M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 4.66M shares.

Dilution risk10/10EXTREME
CONFIDENCE: MEDIUM

The float your screener shows is understated 57%: 2.96M reported, 4.66M actual. 1 floorless convertible note and 6 reverse splits can add another 4,847% of the float. This company has cut its own floor prices before.

  • Variable-rate preferred (death spiral). Series C converts at 85% of the lowest trading price with no fixed price in play: the $125 cap is about 250x the current price.

  • Preferred warrant overhang. 9,400 Series C warrants ($94M) let Hexstone keep creating new variable-price preferred.

  • Pending resale registration. A 6.5M-share Hexstone resale S-1 is pending.

From today's float to the ceiling

shares
4.66M
Estimated float
tradeable today
+0 can sell now
4.66M
Effective supply
float plus what sells on notice
+230.61M if floors are cut and warrants exercise
235.26M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
4.66M
Can sell now
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
4.66M
Converts only if floors are cut
Convertible notes
At the stated conversion prices; a cut to those prices raises the count.
+301.1K
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+4.70M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+220.74M
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+4.87M
Fully diluted
235.26M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$28.93M
Shares outstanding
103.31M
Reported float
2.96M
Avg volume
52.8K
Reverse splits
6 · latest 1-for-25 · May 18, 2026
Going concern
Yes · 0.6 quarters runway
Quarterly burn
$1.36M

Market data as of Oct 26, 2026

Key dates

  • Oct 28, 2026 · Rule 144 eligibility for 1.32M April 2026 services shares
  • Jan 24, 2027 · Rule 144 eligibility for 3.5M July 2026 services shares
  • Nov 4, 2027 · Series C Warrant expiration